Other Clinical Trial - A Multi-center, Comparative Clinical Trial to

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Transforaminal Lumbar Interbody Fusion

See also
Status	Clinical Trial	Phase
Terminated	`NCT04645264` - Effect of Catheter on Postoperative Urinary Retention	N/A
Completed	`NCT03560401` - Is Postoperative Bracing Necessary After Spine Surgery for Degenerative Conditions	N/A
Recruiting	`NCT03856554` - Unilateral Versus Bilateral TLIF for Degenerative Lumbar Spondylolisthesis	N/A

See also

Status

Clinical Trial

Phase

Terminated

NCT04645264 - Effect of Catheter on Postoperative Urinary Retention

N/A

Completed

NCT03560401 - Is Postoperative Bracing Necessary After Spine Surgery for Degenerative Conditions

N/A

Recruiting

NCT03856554 - Unilateral Versus Bilateral TLIF for Degenerative Lumbar Spondylolisthesis

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02504242
Study type	Interventional
Source	BioAlpha Inc.
Contact
Status	Enrolling by invitation
Phase	Phase 3
Start date	April 2015

A Multi-center, Comparative Clinical Trial to Evaluate the Efficacy and Safety of Inject BMP in Patients Undergoing Transforaminal Lumbar Interbody Fusion

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms